Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -71.83% is 13% below its 5-year average of -63.77%, near the high end of its 5-year range (-353.92%–-37.58%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.87% below its 12-month average of -55.74%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -71.83%.
RETURN ON EQUITY (ROE)
-71.83%
RETURN ON EQUITY (ROE) AVG TTM
-55.74%
RETURN ON EQUITY (ROE) AVG 3Y
-75.80%
RETURN ON EQUITY (ROE) AVG 5Y
-63.77%
RETURN ON EQUITY (ROE) AVG 10Y
-93.62%
RETURN ON EQUITY (ROE) AVG 15Y
-93.63%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.87%
CURRENT VS 3Y AVG
+5.23%
CURRENT VS 5Y AVG
-12.63%
CURRENT VS 10Y AVG
+23.27%
CURRENT VS 15Y AVG
+23.28%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-70.98%
vs the sector median at left
Tonix Pharmaceuticals Holding Corp.
Market Cap
$122.66M
Return on Equity (ROE)
-71.83%
TTM Avg
-55.74%
3Y Avg
-75.80%
5Y Avg
-63.77%
Market Cap
$122.43M
Return on Equity (ROE)
-5.10%
TTM Avg
-4.24%
3Y Avg
-6.16%
5Y Avg
0.09%
Market Cap
$124.18M
Return on Equity (ROE)
-165.57%
TTM Avg
-146.09%
3Y Avg
30.63%
5Y Avg
465.14%
Market Cap
$124.70M
Return on Equity (ROE)
-234.42%
TTM Avg
-102.69%
3Y Avg
-100.55%
5Y Avg
-100.92%
Market Cap
$120.58M
Return on Equity (ROE)
-2.13%
TTM Avg
-45.09%
3Y Avg
-61.80%
5Y Avg
-44.27%
Market Cap
$120.41M
Return on Equity (ROE)
-30.12%
TTM Avg
-27.41%
3Y Avg
-24.34%
5Y Avg
-19.85%
Market Cap
$119.84M
Return on Equity (ROE)
-663.38%
TTM Avg
-427.48%
3Y Avg
-294.92%
5Y Avg
-251.31%
Market Cap
$118.83M
Return on Equity (ROE)
-57.47%
TTM Avg
-26.63%
3Y Avg
16.73%
5Y Avg
210.40%
Market Cap
$118.59M
Return on Equity (ROE)
-148.56%
TTM Avg
-96.59%
3Y Avg
-83.25%
5Y Avg
-64.44%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $122.66M | -71.83% | -55.74% | -75.80% | -63.77% |
| BGM Group Ltd. (BGM)vs › | $122.43M | -5.10% | -4.24% | -6.16% | 0.09% |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | -165.57% | -146.09% | 30.63% | 465.14% |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | -234.42% | -102.69% | -100.55% | -100.92% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | -2.13% | -45.09% | -61.80% | -44.27% |
| Seer, Inc. (SEER)vs › | $120.41M | -30.12% | -27.41% | -24.34% | -19.85% |
| Cibus, Inc. (CBUS)vs › | $119.84M | -663.38% | -427.48% | -294.92% | -251.31% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | -57.47% | -26.63% | 16.73% | 210.40% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | -148.56% | -96.59% | -83.25% | -64.44% |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A | 143.89% | 2.05% | -53.47% |
ROE
-71.8%
ROA
-62.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -71.83% |
| 2026-03-31 | -64.89% |
| 2025-12-31 | -50.59% |
| 2025-09-30 | -42.93% |
| 2025-06-30 | -48.47% |
| 2025-03-31 | -73.13% |
| 2024-12-31 | -93.18% |
| 2024-09-30 | -182.25% |
| 2024-06-30 | -353.92% |
| 2024-03-31 | -91.17% |
| 2023-12-31 | -110.55% |
| 2023-09-30 | -100.15% |
| 2023-06-30 | -86.87% |
| 2023-03-31 | -70.61% |
| 2022-12-31 | -53.20% |
| 2022-09-30 | -47.22% |
| 2022-06-30 | -37.58% |
| 2022-03-31 | -47.15% |
| 2021-12-31 | -42.19% |
| 2021-09-30 | -39.44% |
| 2021-06-30 | -40.57% |
| 2021-03-31 | -36.09% |
| 2020-12-31 | -57.57% |
| 2020-09-30 | -71.32% |
| 2020-06-30 | -75.55% |
| 2020-03-31 | -102.83% |
| 2019-12-31 | -330.17% |
| 2019-09-30 | -312.18% |
| 2019-06-30 | -221.54% |
| 2019-03-31 | -160.87% |
| 2018-12-31 | -124.05% |
| 2018-09-30 | -175.02% |
| 2018-06-30 | -153.40% |
| 2018-03-31 | -123.55% |
| 2017-12-31 | -85.81% |
| 2017-09-30 | -80.59% |
| 2017-06-30 | -73.31% |
| 2017-03-31 | -136.20% |
| 2016-12-31 | -153.16% |
| 2016-09-30 | -164.99% |
| 2016-06-30 | -167.78% |
| 2016-03-31 | -191.49% |
| 2015-12-31 | -119.35% |
| 2015-09-30 | -82.97% |
| 2015-06-30 | -81.85% |
| 2015-03-31 | -56.49% |
| 2014-12-31 | -76.52% |
| 2014-09-30 | -51.02% |
| 2014-06-30 | -42.20% |
| 2014-03-31 | -29.31% |
| 2013-12-31 | -167.14% |
| 2013-09-30 | -132.07% |
| 2012-12-31 | -531.24% |
| 2010-06-30 | -374.94% |
| 2010-03-31 | -415.13% |
| 2009-12-31 | -256.31% |
| 2009-09-30 | -196.67% |
| 2009-06-30 | -174.07% |
| 2009-03-31 | -71.63% |
| 2008-12-31 | -49.25% |
